Diagnosis and Management of Insect Allergy: Barriers and Facilitators in the United States

John C Carlson; Monica Hajirawala; Nina Hein

doi:10.2147/JAA.S364867

Diagnosis and Management of Insect Allergy: Barriers and Facilitators in the United States

J Asthma Allergy. 2022 Dec 15:15:1773-1781. doi: 10.2147/JAA.S364867. eCollection 2022.

Authors

John C Carlson¹, Monica Hajirawala², Nina Hein³

Affiliations

¹ Department of Pediatrics, Ochsner Health System, New Orleans, LA, USA.
² Department of Pediatric Allergy and Immunology, University of South Florida, St. Petersburg, FL, USA.
³ Department of Allergy and Clinical Immunology, Tulane University, New Orleans, LA, USA.

Abstract

While guidelines recommend testing and treatment for patients with venom-induced anaphylaxis to prevent morbidity and mortality, significant barriers prevent most patients from receiving the evaluation and treatments that they need. This review examines these barriers in the United States along with the facilitators that can be used to overcome them.

Keywords: anaphylaxis; immunotherapy; insect hypersensitivity; social determinants of health; venom.

Publication types

Review